Bannoud, N., Stupirski, J. C., Cagnoni, A., Hockl, P. F., Pérez Sáez, J. M., García, P. A., . . . Rabinovich, G. A. (2023). Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology. Web
Citación estilo ChicagoBannoud, Nadia, et al. Circulating Galectin-1 Delineates Response to Bevacizumab in Melanoma Patients and Reprograms Endothelial Cell Biology. 2023.
Cita MLABannoud, Nadia, et al. Circulating Galectin-1 Delineates Response to Bevacizumab in Melanoma Patients and Reprograms Endothelial Cell Biology. 2023.
Precaución: Estas citas no son 100% exactas.